Reuters Pharma USA 2024 – Meruno Perugini
Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Newsletters and Deep Dive digital magazine
Innovation in pharma comes in many forms, but at the end of the day what the industry cares about is results.
Katherine Forbes, director of innovation and enterprise at Kidney Research UK, discusses the unique, evolving role of medical research charities in facilitating collaborative partnerships a
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t
The recent acquisition of ImmunoGen by AbbVie, which followed the earlier acquisition of Seagen by Pfizer, has brought renewed attention to antibody-drug conjugates (ADCs), highlighting the
Editor's Picks
Newsletters and Deep Dive
digital magazine